Imbria Pharmaceuticals
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
265 Franklin St Ste 1702, Boston, Massac...Phone Number
(617) 675-4060Website
www.imbria.comRevenue
<$5 MillionIndustry
About Imbria Pharmaceuticals
Imbria is a clinical-stage company focused on developing innovative therapies that enhance cellular energy to treat cardiometabolic disorders, particularly cardiovascular issues. Their pipeline includes treatments for conditions such as non-obstructive hypertrophic cardiomyopathy, stable angina, and heart failure with preserved ejection fraction. The company is dedicated to translating cellular metabolism insights into effective medicines for patients who currently face limited treatment options. Imbria aims to improve patients' lives by advancing new therapies that address significant cardiometabolic health challenges.Explore more
Imbria Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Imbria Pharmaceuticals
Compare insights from companies similar to Imbria Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Imbria Pharmaceuticals Tech Stack
A closer look at the technologies used by Imbria Pharmaceuticals
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Imbria Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Imbria is a clinical-stage company focused on developing innovative therapies that enhance cellular energy to treat cardiometabolic disorders, particularly cardiovascular issues. Their pipeline includes treatments for conditions such as non-obstructive hypertrophic cardiomyopathy, stable angina, and heart failure with preserved ejection fraction. T... Read More
